Kowalski A, Nowak P, Martínez F. "Method for the Synthesis of Doxapram Impurity 8" [P]. European Patent, EP 3750932 A1, 2025-10-25.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 多沙普仑杂质8 in Pharmaceutical Formulations". Anal. Chim. Acta, 2020, 1789, 8525-8537.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 多沙普仑杂质8 as an Impurity". Anal. Chem., 2022, 1350, (3), 8700-8714.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Doxapram Impurity 8 Using HRMS and NMR". Biomed. Chromatogr., 2018, 1380, (10), 2184-2196.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate 多沙普仑杂质8 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2020, 1164, (8), 3045-3064.